Skip to content

Budesonide EP Impurity A

Budesonide EP Impurity A

Product Description
CAT No.
ALN-B022002
CAS No.
13951-70-7
Mol. F.
C21H28O6
Mol. Wt.
376.4
Stock
Please Inquire
Chemical Name : 11β,16α,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione (as per EP & USP)
Smiles : C[C@@]12[C@](C(CO)=O)(O)[C@@](O)([H])C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O
Inchi : InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
Synonym : 16alpha-Hydroxyprednisolone ; 16α-Hydroxylprednisolone (USP)

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation